Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

FDA Approves Low-Dose Climara Pro (Estradiol/Levonorgestrel) Transdermal Hormone Therapy BERLIN, GERMANY -- November 24, 2003 -- Schering AG, Germany (NYSE: SHR; FSE: SCH) announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Climara Pro® (estradiol/levonorgestrel transdermal system) for the treatment of menopausal symptoms. Climara Pro, a thin, translucent patch, is the first once-a-week combined hormone therapy approved in the U.S. It will be marketed by Schering's U.S. subsidiary, Berlex, Inc. which plans to launch Climara Pro in January 2004. "Climara Pro will provide women with low doses of two well-accepted hormones," said Dr. Philip Smits, Head of Schering AG's Gynecology & Andrology. "Hormone treatment is one of the most effective ways to alleviate menopausal symptoms. Schering is committed to providing the best care in this field." Transdermal (patch) technology allows for continuous delivery of hormones at doses much lower than in pills. Climara Pro delivers 0.015 mg per day of levonorgestrel and 0.045 mg per day of estradiol. Estradiol is the most active estrogen made by the ovary. This therapy is approved for the relief of moderate to severe vasomotor symptoms associated with menopause, such as hot flashes and night sweats. Additional information: Climara Pro is a transdermal hormone therapy (HT) with levonorgestrel, a progestin that has been used worldwide in a variety of women's healthcare products for more than 20 years with millions of patient-years of experience. This patch also contains estradiol, an estrogen that is identical to the estrogen a woman's body produces before menopause. Easily affixed to the skin, Climara Pro delivers 0.015 mg per day of levonorgestrel and 0.045 mg per day of estradiol transdermally, allowing for continuous delivery of hormones at doses much lower than in pills. Like Climara (transdermal estradiol system), Schering's once-a-week estrogen-only patch, Climara Pro delivers hormones continuously and directly, with the benefits of unique 3M Drug Delivery Systems technology. With the addition of levonorgestrel, Climara Pro is indicated for use by women with an intact uterus, whereas Climara is appropriate for women who have had a hysterectomy. SOURCE: Schering AG E-mail this page to a friend or colleague! To print, use this version